Search PubMed⌕ Search

Biomedical subjects

A Mazurowa

Publications and source records attributed to A Mazurowa.

64 records · Page 4Linked to original sources

[Proportion of B- and T-lymphocytes in lymph nodes removed from patients with Hodgkin's disease].

The proportions of T and B lymphocytes were determined in lymph nodes removed from 30 patients with Hodgkin's disease and in 18 control lymph nodes. In all lymph nodes obtained from patients with Hodgkin's disease histological examination demonstrated presence of typical granulation tissue of type Ns, Mc, Ld (changes of Lp type were not found). In the control lymph nodes no neoplastic changes or inflammatory reactions were observed. For identification of T cells the rosette test E was used and for identification of B cells --- the EAC rosette test and tests for presence of Ig on their surface by the immunofluorescent method (L Ig+). It was found that the proportions of T and B cells in the lymph nodes obtained from patients with Hodgkin's disease were not different from those in control lymph nodes. The percent values of T and B cells were similar in all three histological types of changes in Hodgkin's disease. Early radiotherapy was not connected with a change in T and B cell proportions in the irradiated lymph nodes.

B-Lymphocytes↗

[T and B lymphocytes in peripheral blood of subjects receiving atropine].

Using the rosette test E and EAC and determining presence of immunoglobulins on the surface of cells T and B lymphocyte counts were calculated in peripheral blood of 10 healthy subjects receiving atropine for some days. Parallely the activity of T cells was evaluated on the basis of blastic transformation degree after PHA stimulation. No differences were observed in the counts of T and B lymphocytes in peripheral blood before and during atropine administration. T lymphocytes showed, however, functional defects manifested with impairment of PHA-stimulated transformation.

Adult↗

[Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers].

On the basis of standardized protocols of the therapeutic results of acute non-lymphoblastic leukaemias in adults sent to the Institute of Haematology in Warsaw from 8 haematological centres in Poland it was demonstrated that complete remission occurred in 34.4% of patients (129 out of 375 cases). The mean survival time of the patients treated intensively according to programmes I, II, III and IV 8.6 months, those of patients with complete remission - 13.5 months, patients without complete remission - 3.7 months. The most frequent cause of death (82.5%) were infections and/or haemarrhagic diathesis.

Acute Disease↗